Trial Profile
Solifenacin Succinate vs. Fesoterodine A Comparison Trial for the Treatment of Bothersome Urgency Symptoms
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Fesoterodine (Primary) ; Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 15 May 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 15 May 2012 New trial record